Abstract PS5-01-18: Dalpiciclib Plus Pyrotinib Plus Letrozole for Patients with Estrogen Receptor-Positive and HER2-Positive Metastatic Breast Cancer (DAPLET)
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Institution: Zhejiang Cancer Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7129695565
Cites:
Cited by:
Related to:
